Lacroix, André

Cushing's syndrome

Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet

Pituitary Gland Disorders and TreatmentsAdrenal and Paraganglionic Tumors

Cited by 1,777

Diagnosis and complications of Cushing’s syndrome: a consensus statement

Arnaldi, G., Angeli, A., Atkinson, A. B., Bertagna, X., Cavagnini, F., Chrousos, G. P., Fava, G. A., Findling, J. W., Gaillard, R. C., Grossman, A. B., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism

Pituitary Gland Disorders and TreatmentsAdrenal and Paraganglionic Tumors

Cited by 1,362

Consensus on diagnosis and management of Cushing's disease: a guideline update

Fleseriu, M., Auchus, R., Bancos, I., Ben-Shlomo, A., Bertherat, J., Biermasz, N. R., Boguszewski, C. L., Bronstein, M. D., Buchfelder, M., Carmichael, J. D., et al. (2021) · The Lancet Diabetes & Endocrinology

Pituitary Gland Disorders and TreatmentsAdrenal and Paraganglionic Tumors

Cited by 953

Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement

Biller, B. M. K., Grossman, A. B., Stewart, P. M., Melmed, S., Bertagna, X., Bertherat, J., Buchfelder, M., Colao, A., Hermus, A. R., Hofland, L. J., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism

Pituitary Gland Disorders and TreatmentsAdrenal and Paraganglionic Tumors

Cited by 853

Leuprolide acetate therapy in luteinizing hormone-dependent Cushing's syndrome.

Lacroix, A., Hamet, P., & Boutin, J.-M. (1999) · New England Journal of Medicine

Pituitary Gland Disorders and TreatmentsAdrenal Hormones and Disorders

Cited by 244

Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase

Pivonello, R., Fleseriu, M., Newell-Price, J., Bertagna, X., Findling, J., Shimatsu, A., Gu, F., Auchus, R., Leelawattana, R., Lee, E. J., et al. (2020) · The Lancet Diabetes & Endocrinology

Pituitary Gland Disorders and TreatmentsAdrenal Hormones and Disorders

Cited by 222

Propranolol therapy for ectopic β-adrenergic receptors in adrenal Cushing's syndrome.

Lacroix, A., Tremblay, J., Rousseau, G., Bouvier, M., & Hamet, P. (1997) · New England Journal of Medicine

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 204

Cabergoline monotherapy in the long-term treatment of Cushing's disease

Godbout, A., Manavela, M., Danilowicz, K., Beauregard, H., Bruno, O. D., & Lacroix, A. (2010) · European Journal of Endocrinology

Pituitary Gland Disorders and TreatmentsNeuroendocrine Tumor Research Advances

Cited by 202

ARMC5 Mutations Are a Frequent Cause of Primary Macronodular Adrenal Hyperplasia

Alencar, G. A., Lerario, A. M., Nishi, M. Y., Mariani, B. M. D. P., Almeida, M. Q., Tremblay, J., Hamet, P., Bourdeau, I., Zerbini, M. C. N., Pereira, M. A. A., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 162

Management of endocrine disease: differential diagnosis, investigation and therapy of bilateral adrenal incidentalomas

Bourdeau, I., El Ghorayeb, N., Gagnon, N., & Lacroix, A. (2018) · European Journal of Endocrinology

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 98

Multiple aberrant hormone receptors in Cushing’s syndrome

Ghorayeb, N. E., Bourdeau, I., & Lacroix, A. (2015) · European Journal of Endocrinology

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 90

Primary bilateral macronodular adrenal hyperplasia

De Venanzi, A., Alencar, G. A., Bourdeau, I., Fragoso, M. C. B. V., & Lacroix, A. (2014) · Current Opinion in Endocrinology, Diabetes & Obesity

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 73

Use of late-night salivary cortisol to monitor response to medical treatment in Cushing's disease

Newell-Price, J., Pivonello, R., Tabarin, A., Fleseriu, M., Witek, P., Gadelha, M. R., Petersenn, S., Tauchmanova, L., Ravichandran, S., Gupta, P., et al. (2020) · European Journal of Endocrinology

Pituitary Gland Disorders and TreatmentsAdrenal Hormones and Disorders

Cited by 60

Adrenocortical hyperplasia: A multifaceted disease

Bourdeau, I., Parisien-La Salle, S., & Lacroix, A. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 48

Adrenal incidentalomas and subclinical Cushing's syndrome: diagnosis and treatment.

Mazzuco, T. L., Bourdeau, I., & Lacroix, A. (2009) · Current Opinion in Endocrinology, Diabetes & Obesity

Adrenal and Paraganglionic TumorsPituitary Gland Disorders and Treatments

Cited by 48

Pasireotide monotherapy in Cushing’s disease: a single-centre experience with 5-year extension of phase III Trial

MacKenzie Feder, J., Bourdeau, I., Vallette, S., Beauregard, H., Ste-Marie, L.-G., & Lacroix, A. (2014) · Pituitary

Pituitary Gland Disorders and TreatmentsAdrenal and Paraganglionic Tumors

Cited by 38

The Pituitary-Thyroid Axis after Hemithyroidectomy in Euthyroid Man

MATTE, R., STE-MARIE, L. G., COMTOIS, R., D'AMOUR, P., LACROIX, A., CHARTRAND, R., POISSON, R., & BASTOMSKY, C. H. (1981) · The Journal of Clinical Endocrinology & Metabolism

Thyroid Disorders and TreatmentsThyroid and Parathyroid Surgery

Cited by 29

Improved clinical outcomes during long-term osilodrostat treatment of Cushing disease with normalization of late-night salivary cortisol and urinary free cortisol

Newell-Price, J., Fleseriu, M., Pivonello, R., Feelders, R. A., Gadelha, M. R., Lacroix, A., Witek, P., Heaney, A. P., Piacentini, A., Pedroncelli, A. M., et al. (2024) · Journal of the Endocrine Society

Pituitary Gland Disorders and TreatmentsAdrenal Hormones and Disorders

Cited by 21

Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement.

Hamidi, O., St-Jean, M., Lacroix, A., & Bancos, I. (2026) · The Journal of Clinical Endocrinology & Metabolism

Pituitary Gland Disorders and TreatmentsAdrenal Hormones and Disorders

Cited by 5